Day: March 2, 2022

“If Canopy declines to file an appeal…this would cement GW’s victory and bode well for others in the CO2 extraction industry.” By Larry Sandell, Mei & Mark, LLP Another chapter of Canopy Growth Corp.’s cannabis extraction patent enforcement campaign against GW Pharmaceuticals and its CBD-based drug, Epidiolex ®, has comeContinue Reading

A pair of Missouri lawmakers on Tuesday filed resolutions urging President Joe Biden to end marijuana criminalization, provide executive relief to those caught up in the drug war and condemn what some view as racial disparities in how athletic organizations apply drug testing standards. Missouri has become a hotbed forContinue Reading

Because Blake Pearson is a board-certified physician in Canada—where cannabis is legal under national law—unlike his US colleagues, who can only prescribe a single FDA-approved CBD pharmaceutical and may only “recommend” high-THC cannabis, Pearson can prescribe cannabis to his patients. And he does: CBD for autism, THC for dementia—always in precise amounts, alwaysContinue Reading